Suzanne Ildstad Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Suzanne Ildstad is Director of Talaris Therapeutics, Inc.. Currently has a direct ownership of 3.77 Million shares of TALS, which is worth approximately $10.3 Million. The most recent transaction as insider was on Jun 14, 2023, when has been sold 12,942 shares (Common Stock) at a price of $2.49 per share, resulting in proceeds of $32,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.77M
0% 3M change
0% 12M change
Total Value Held $10.3 Million

Suzanne Ildstad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
SELL
Open market or private sale
$32,225 $2.49 p/Share
12,942 Reduced 0.34%
3,771,392 Common Stock
Jun 13 2023
SELL
Open market or private sale
$36,372 $2.56 p/Share
14,208 Reduced 0.37%
3,784,334 Common Stock
Jun 12 2023
SELL
Open market or private sale
$43,693 $2.59 p/Share
16,870 Reduced 0.44%
3,798,542 Common Stock
Jun 09 2023
SELL
Open market or private sale
$62,530 $2.46 p/Share
25,419 Reduced 0.66%
3,815,412 Common Stock
Jun 08 2023
SELL
Open market or private sale
$100,792 $2.48 p/Share
40,642 Reduced 1.05%
3,840,831 Common Stock
Jun 07 2023
SELL
Open market or private sale
$179,252 $2.39 p/Share
75,001 Reduced 1.9%
3,881,473 Common Stock
Jun 06 2023
SELL
Open market or private sale
$64,638 $2.53 p/Share
25,549 Reduced 0.92%
2,756,474 Common Stock
Jun 05 2023
SELL
Open market or private sale
$19,759 $2.52 p/Share
7,841 Reduced 0.28%
2,782,023 Common Stock
Jun 02 2023
SELL
Open market or private sale
$39,545 $2.5 p/Share
15,818 Reduced 0.56%
2,789,864 Common Stock
Jun 01 2023
SELL
Open market or private sale
$40,225 $2.56 p/Share
15,713 Reduced 0.56%
2,805,682 Common Stock
Apr 21 2023
SELL
Open market or private sale
$35,259 $2.35 p/Share
15,004 Reduced 0.53%
2,821,395 Common Stock
Apr 20 2023
SELL
Open market or private sale
$109,486 $2.33 p/Share
46,990 Reduced 1.63%
2,836,399 Common Stock
Apr 19 2023
SELL
Open market or private sale
$46,986 $2.16 p/Share
21,753 Reduced 0.75%
2,883,389 Common Stock
Apr 18 2023
SELL
Open market or private sale
$105,803 $2.15 p/Share
49,211 Reduced 1.67%
2,905,142 Common Stock
Apr 17 2023
SELL
Open market or private sale
$213,509 $2.14 p/Share
99,771 Reduced 3.27%
2,954,353 Common Stock
Mar 17 2023
SELL
Open market or private sale
$21,498 $2.06 p/Share
10,436 Reduced 0.34%
3,054,124 Common Stock
Mar 03 2023
SELL
Open market or private sale
$14,020 $2.06 p/Share
6,806 Reduced 0.22%
3,064,560 Common Stock
Mar 01 2023
SELL
Open market or private sale
$59 $2.05 p/Share
29 Reduced 0.0%
3,071,366 Common Stock
Feb 21 2023
SELL
Open market or private sale
$7,174 $2.05 p/Share
3,500 Reduced 0.11%
3,071,395 Common Stock
Feb 17 2023
SELL
Open market or private sale
$7,404 $2.05 p/Share
3,612 Reduced 0.12%
3,074,895 Common Stock
Feb 16 2023
SELL
Open market or private sale
$6,054 $2.06 p/Share
2,939 Reduced 0.1%
3,078,507 Common Stock
Aug 22 2022
SELL
Open market or private sale
$1,470,000 $2.8 p/Share
525,000 Reduced 14.56%
3,081,446 Common Stock
Nov 17 2021
SELL
Bona fide gift
-
1,200,000 Reduced 24.97%
3,606,446 Common Stock
SI

Suzanne Ildstad

Director
Louisville, KY

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS